Create A 10-12 Slide PowerPoint To Identify Med

Create a 10–12-slide PowerPoint presentation to identify medications associated with a chosen disease or health condition, explain the actions and side effects of the medications, and discuss any controversies related to the medications

Please Check The Competences At The End This Is How I Get The Points

Please Check The Competences At The End This Is How I Get The Points

PLEASE CHECK THE COMPETENCES AT THE END; THIS IS HOW I GET THE POINTS!!! Create a 10–12-slide PowerPoint presentation to identify medications associated with a chosen disease or health condition, explain the actions and side effects of the medications, and discuss any controversies related to the medications. Explain a treatment regime, including pharmacology, for the disease or health condition you selected, along with how the treatment regime may affect a client's lifestyle. Imagine your supervisor has asked you to conduct a lunch and learn session to educate your fellow nursing staff on pharmacological interventions. Preparation: Select a disease or health condition that requires pharmacological intervention.

You may choose any disease or health condition you wish, but the disease or health condition must be relevant to nurses from a variety of settings (for example: ER, pediatrics, public health, et cetera). Requirements: Once you have selected a disease or health condition, create a PowerPoint presentation you could use in your lunch and learn session, including the following: · Identify the disease or health condition you have chosen, along with the areas where nurses are likely to see it. (Do this in the agenda slide or next slide after the agenda.) · Identify the three drugs used most often in the treatment of the disease or health condition. · Explain the types of actions, side effects, indications, and contraindications that could be expected from the pharmacological treatment. · Describe the treatment regime most often prescribed for the disease or health condition. This should include pharmacology but not be limited to pharmacology. · Explain how the treatment regime (including pharmacology) may impact a client's lifestyle. Consider things such as finances, ease or complexity of administration, instructions (frequency, duration), et cetera. · Describe how a nurse should monitor a client being treated for the disease or health condition in order to obtain a quality patient outcome. · Explain any controversies associated with the drugs used in the treatment. For example, is there a black box warning with any of the drugs? Use the notes section of each slide to expand your points or draft your mock oral presentation (or both) and reference your resources. Use at least 3 peer-reviewed or professional resources to support your work in this assessment.

Be sure your PowerPoint includes a title slide, a slide with your agenda or list of topics to be covered, and a reference slide. Follow current APA style and formatting guidelines for your citations and references. Additional Requirements · Number of slides: 10–12, not including the title and reference slides. · Be creative. Consider your intended audience. By successfully completing this assessment, you will demonstrate your proficiency in the following course competencies and assessment criteria: · Competency 1: Apply practice guidelines and standards of evidence-based practice related to pharmacology for safe and effective nursing practice. o Identify the pharmacological agents most often used in the treatment of a disease or health condition. o Describe the treatment regime, including pharmacology, most often prescribed for a disease or health condition. o Explain the controversies related to a pharmacological agent. · Competency 2: Explain the relationship between quality patient outcomes, patient safety, and the appropriate use of pharmacology and psychopharmacology. o Explain the types of actions, side effects, indications, and contraindications that may be expected from a pharmacological treatment. o Describe how a treatment regime, including pharmacology, may impact a client's lifestyle. o Describe how to monitor a client following a prescribed treatment regime, including pharmacology, in order to obtain a quality patient outcome. · Competency 4: Communicate in a manner that is scholarly, professional, and consistent with expectations of a nursing professional. o Write content clearly and logically with correct use of grammar, punctuation, and mechanics. o Correctly format citations and references using current APA style.

Paper For Above instruction

The development of pharmacological interventions plays a crucial role in managing various diseases and health conditions across diverse healthcare settings. For nurses working in emergency rooms, pediatrics, and public health, understanding the medications used, their actions, side effects, and controversies is vital for ensuring safe and effective patient care. This presentation focuses on a specific disease—Type 2 Diabetes Mellitus—highlighting the medications most commonly prescribed, their pharmacological mechanisms, treatment regime implications, and monitoring strategies to optimize patient outcomes.

Introduction to Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. It is prevalent worldwide and often presents in adult populations, though increasing incidence in pediatrics has been noted. Healthcare professionals, including nurses, frequently encounter T2DM in various settings, making it essential to understand pharmacological interventions. Nurses are instrumental in administering medications, monitoring responses, and educating patients about managing their condition effectively.

Common Pharmacological Agents in T2DM

Three primary classes of medications are used in managing T2DM: Biguanides (Metformin), Sulfonylureas (Glipizide), and Dipeptidyl Peptidase-4 (DPP-4) inhibitors (Sitagliptin). These medications select different mechanisms to improve glycemic control.

Metformin

Metformin is the first-line pharmacological treatment for T2DM. It works primarily by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It has a favorable safety profile but can cause gastrointestinal side effects such as diarrhea and nausea, and rare risk of lactic acidosis in contraindicated populations (Rizzo & Kritchevsky, 2021).

Glipizide (Sulfonylurea)

Glipizide stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Its side effects include hypoglycemia and weight gain. Contraindications include sulfa allergy and in patients with severe renal or hepatic impairment (American Diabetes Association, 2022).

Sitagliptin (DPP-4 inhibitor)

Sitagliptin enhances incretin hormone activity, increasing insulin secretion and decreasing glucagon levels. It generally has a mild side effect profile but has been linked to pancreatitis in rare cases (Norris et al., 2020).

Pharmacological Actions, Indications, and Contraindications

These medications act on different pathways to control blood glucose levels. While effective, they carry contraindications such as renal impairment for Metformin, sulfa allergies for Glipizide, and a history of pancreatitis for Sitagliptin. Side effects may include gastrointestinal discomfort, hypoglycemia, and potential risk of pancreatitis, necessitating careful patient monitoring.

Treatment Regimen and Pharmacology

The typical treatment regime for T2DM often involves initiating Metformin alongside lifestyle modifications. If glycemic targets are not achieved, additional agents like Sulfonylureas or DPP-4 inhibitors may be added. Pharmacologically, the combination aims to target different pathways involved in glucose regulation to maximize efficacy and minimize side effects (American Diabetes Association, 2022).

Impact on Client's Lifestyle

The pharmacological treatment regime impacts patients' lifestyles considering factors such as medication costs, administration complexity, and side effect management. For example, some medications require strict adherence to dosing schedules, and hypoglycemia risk can influence dietary and activity choices. Educating patients on medication adherence and recognizing adverse effects are crucial roles of nursing care.

Nursing Monitoring and Patient Outcomes

Effective nurse monitoring includes regular blood glucose testing, assessing for side effects, and ensuring medication adherence. Monitoring for hypoglycemia is particularly important with secretagogues like Glipizide. Adjusting treatment based on patient responses and lab results helps achieve optimal glycemic control and reduces complications (Sharma & Kedia, 2021).

Controversies in Pharmacological Treatment of T2DM

Controversies include concerns over the risk of lactic acidosis with Metformin in certain populations, and the potential link between DPP-4 inhibitors and pancreatitis. Black box warnings exist for some medications, emphasizing the importance of personalized treatment plans and vigilant monitoring. Ongoing research continues to evaluate the safety of these agents to refine guidelines and improve patient safety (Rizzo & Kritchevsky, 2021; Norris et al., 2020).

Conclusion

Management of T2DM with pharmacological agents requires a comprehensive understanding of the medications, their actions, side effects, and associated controversies. Nurses play a pivotal role in medication administration, patient education, and monitoring, which directly influence treatment outcomes. Staying informed about emerging evidence and controversies ensures safe, effective, and patient-centered care.

References

• American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement 1), S1–S264.
• Norris, S. L., et al. (2020). Safety of DPP-4 inhibitors in diabetes: A systematic review and meta-analysis. Diabetes & Metabolism, 46(1), 1-10.
• Rizzo, M., & Kritchevsky, S. (2021). The safety profile of metformin: A review. Journal of Clinical Endocrinology & Metabolism, 106(4), 1022–1028.
• Sharma, A., & Kedia, N. (2021). Nursing roles in diabetes management: Monitoring and patient education. Journal of Nursing Practice, 35(4), 178-185.